Search results
Results from the Health.Zone Content Network
Radiation protection, also known as radiological protection, is defined by the International Atomic Energy Agency (IAEA) as "The protection of people from harmful effects of exposure to ionizing radiation, and the means for achieving this". [1] Exposure can be from a source of radiation external to the human body or due to internal irradiation ...
The Center for Devices and Radiological Health ( CDRH) is the branch of the United States Food and Drug Administration (FDA) responsible for the premarket approval of all medical devices, as well as overseeing the manufacturing, performance and safety of these devices. The CDRH also oversees the radiation safety performance of non-medical ...
Unprotected experiments in the U.S. in 1896 with an early X-ray tube (Crookes tube), when the dangers of radiation were largely unknown.The history of radiation protection begins at the turn of the 19th and 20th centuries with the realization that ionizing radiation from natural and artificial sources can have harmful effects on living organisms.
Radiation therapy is a cancer treatment that uses high-energy waves to damage or destroy cancer cells. The waves stop cancer cells from growing and making more cancer cells by affecting the DNA ...
Signed into law by President Lyndon B. Johnson on October 18, 1968. Radiation Control for Health and Safety Act of 1968 was an amendment to the Public Health Service Act mandating performance standards for electronic products suspectible of electromagnetic radiation or radiation emissions. The United States statute established provisions ...
Areas covered by the Radiation Exposure Compensation Program. The United States Radiation Exposure Compensation Act (RECA) is a federal statute implemented in 1990, set to expire in July 2024, providing for the monetary compensation of people, including atomic veterans, who contracted cancer and a number of other specified diseases as a direct result of their exposure to atmospheric nuclear ...
It was merged with the FDA's Bureau of Drugs to form the Center for Drugs and Biologics during an agency-wide reorganization under Commissioner Arthur Hayes. This reorganization similarly merged the bureaus responsible for medical devices and radiation control into the Center for Devices and Radiological Health.
The Center for Drug Evaluation and Research ( CDER, pronounced "see'-der") is a division of the U.S. Food and Drug Administration (FDA) that monitors most drugs as defined in the Food, Drug, and Cosmetic Act. Some biological products are also legally considered drugs, but they are covered by the Center for Biologics Evaluation and Research.